Found 7 matching trials
CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery PHASE4 CCTG 590 is a open-label study to evaluate the impact of therapy intensific...
Show More Location
University Southern California
Learn More & Join Trial
A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments PHASE4 The goal of this clinical study is to provide continued access to the study...
Show More Learn More & Join Trial
Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+ PHASE2 In the vast majority of those infected with HIV virus who are untreated, th...
Show More Location
University Hospital of Point G
Learn More & Join Trial
Pharmacokinetic Properties of Two Dosages Nevirapine Extended Release (XR) Formulations Compared to VIRAMUNE® Tablet as Well as to Nevirapine XR Tablet in Healthy Male Volunteers PHASE1 Study to determine the pharmacokinetic properties of 200 mg (2 x 100 mg tab...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected Patients PHASE2 The primary objective of the study is to compare the tolerance and safety b...
Show More Learn More & Join Trial
Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy PHASE3 In the early 2000s, the "TRILEGE©" study was realized to determine if the r...
Show More Location
Unité des Maladies Infectieuses, CHU de CAEN
Learn More & Join Trial
Pharmacokinetic Properties of Nevirapine Extended Release Tablets When Administered Orally in Healthy Male Volunteers PHASE1 Study to determine the pharmacokinetic properties of 200 mg nevirapine (NVP...
Show More Location
Multiple Locations
Learn More & Join Trial